2025 Q4 -tulosraportti
UUTTA
5 päivää sitten
‧41 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 244 | - | - | ||
| 158 | - | - | ||
| 325 | - | - | ||
| 483 | - | - | ||
| 545 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 13.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.3. | ||
2025 Q3 -tulosraportti 14.11.2025 | ||
2025 Q2 -tulosraportti 22.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 5.3.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·7 t sittenDanish blackbirds have been particularly affected by the deadly Usutu virus, which has now been found in Danish mosquitoes. 16. March 2026 17:21 Ritzau. Why Bavarian could be relevant Bavarian Nordic already has experience with: • mosquito-borne diseases • government vaccine contracts • rapid development of emergency vaccines. For example, they have developed a vaccine against Chikungunya, which is also a mosquito-borne virus. If the EU or USA decides to build up a stock of a West Nile vaccine, Bavarian is a type of company that can typically get such contracts
·6 t sittenBut now, blackbirds are, all things considered, not homo sapiens. And that something transmits from a mosquito to humans doesn't mean much in relation to one mosquito-related vaccine and another mosquito-related vaccine.·6 t sittenIt is the University of Copenhagen that is responsible for the collection, which is part of the EU-funded project OH4Surveillance. Here, 11 European countries collaborate to monitor diseases that can infect both animals and humans. They are called zoonotic diseases. /ritzau/- ·1 päivä sittenA strong signal that Paul Chaplin buys shares privately in Bavarian Nordic for 1,9 mil at a price of 176,65. C25-CEO buys for almost 1,9 mio. kr. Paul Chaplin is CEO of Bavarian Nordic. Paul Chaplin is CEO of Bavarian Nordic. Asger Ladefoged lans Laura Nørkjær Seligmann Journalist The CEO of Bavarian Nordic Paul Chaplin has gone on a share purchase. This can be read in a stock exchange announcement from the Danish vaccine company Thursday evening. He has bought 10.642 shares at an average price of 177,65 kr. He has thus bought shares for almost 1,9 mio. kr. Back in early March, it was announced that Paul Chaplin will step down as CEO of Bavarian Nordic after 27 years in the company. He will remain in the position until the end of 2026 or until the new CEO is found. Paul Chaplin's share purchase took place Thursday, March 12 - the same day Bavarian Nordic released its annual report. However, there was not much excitement associated with the report, as Bavarian Nordic merely maintained the preliminary figures that the company had issued in early February.
·1 päivä sittenThese are RSV shares and thus part of Chaplin's compensation package.1 päivä sitten · Muokattu1 päivä sitten · MuokattuCiterer hermed PR " Køb (overdragelse af Restricted Stock Units)" Der står ikke RSV, men Restricted Stock Units (RSU). Same same..... Drømmer vist stadig om RSV (vaccinen som fejlede big time :-) 
·12.3.Insanely low P/E with new report. Considering buying into this :)
·1 päivä sittenYou should be aware that in 2025 they booked a one-off income of 810 mio kr for the sale of a priority voucher. At the same time, revenue is expected to fall somewhat in 2026 as the peak of mpx vaccines is now nearing completion. The underlying travel vaccine business is growing nicely, however, and especially the new Chikungunya-vaccine is promising, so there can certainly be reasons to buy into the company, but p/E for 2025 should be taken with a grain of salt. And yes, the portfolio you share here on the platform has 100% cash. It can of course be a mistake or you may have several portfolios, but it immediately appears to us others that you have cash.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
UUTTA
5 päivää sitten
‧41 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·7 t sittenDanish blackbirds have been particularly affected by the deadly Usutu virus, which has now been found in Danish mosquitoes. 16. March 2026 17:21 Ritzau. Why Bavarian could be relevant Bavarian Nordic already has experience with: • mosquito-borne diseases • government vaccine contracts • rapid development of emergency vaccines. For example, they have developed a vaccine against Chikungunya, which is also a mosquito-borne virus. If the EU or USA decides to build up a stock of a West Nile vaccine, Bavarian is a type of company that can typically get such contracts·6 t sittenBut now, blackbirds are, all things considered, not homo sapiens. And that something transmits from a mosquito to humans doesn't mean much in relation to one mosquito-related vaccine and another mosquito-related vaccine.·6 t sittenIt is the University of Copenhagen that is responsible for the collection, which is part of the EU-funded project OH4Surveillance. Here, 11 European countries collaborate to monitor diseases that can infect both animals and humans. They are called zoonotic diseases. /ritzau/
- ·1 päivä sittenA strong signal that Paul Chaplin buys shares privately in Bavarian Nordic for 1,9 mil at a price of 176,65. C25-CEO buys for almost 1,9 mio. kr. Paul Chaplin is CEO of Bavarian Nordic. Paul Chaplin is CEO of Bavarian Nordic. Asger Ladefoged lans Laura Nørkjær Seligmann Journalist The CEO of Bavarian Nordic Paul Chaplin has gone on a share purchase. This can be read in a stock exchange announcement from the Danish vaccine company Thursday evening. He has bought 10.642 shares at an average price of 177,65 kr. He has thus bought shares for almost 1,9 mio. kr. Back in early March, it was announced that Paul Chaplin will step down as CEO of Bavarian Nordic after 27 years in the company. He will remain in the position until the end of 2026 or until the new CEO is found. Paul Chaplin's share purchase took place Thursday, March 12 - the same day Bavarian Nordic released its annual report. However, there was not much excitement associated with the report, as Bavarian Nordic merely maintained the preliminary figures that the company had issued in early February.·1 päivä sittenThese are RSV shares and thus part of Chaplin's compensation package.1 päivä sitten · Muokattu1 päivä sitten · MuokattuCiterer hermed PR " Køb (overdragelse af Restricted Stock Units)" Der står ikke RSV, men Restricted Stock Units (RSU). Same same..... Drømmer vist stadig om RSV (vaccinen som fejlede big time :-)
- ·12.3.Insanely low P/E with new report. Considering buying into this :)·1 päivä sittenYou should be aware that in 2025 they booked a one-off income of 810 mio kr for the sale of a priority voucher. At the same time, revenue is expected to fall somewhat in 2026 as the peak of mpx vaccines is now nearing completion. The underlying travel vaccine business is growing nicely, however, and especially the new Chikungunya-vaccine is promising, so there can certainly be reasons to buy into the company, but p/E for 2025 should be taken with a grain of salt. And yes, the portfolio you share here on the platform has 100% cash. It can of course be a mistake or you may have several portfolios, but it immediately appears to us others that you have cash.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 244 | - | - | ||
| 158 | - | - | ||
| 325 | - | - | ||
| 483 | - | - | ||
| 545 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 13.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.3. | ||
2025 Q3 -tulosraportti 14.11.2025 | ||
2025 Q2 -tulosraportti 22.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 5.3.2025 |
2025 Q4 -tulosraportti
UUTTA
5 päivää sitten
‧41 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 13.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.3. | ||
2025 Q3 -tulosraportti 14.11.2025 | ||
2025 Q2 -tulosraportti 22.8.2025 | ||
2025 Q1 -tulosraportti 9.5.2025 | ||
2024 Q4 -tulosraportti 5.3.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·7 t sittenDanish blackbirds have been particularly affected by the deadly Usutu virus, which has now been found in Danish mosquitoes. 16. March 2026 17:21 Ritzau. Why Bavarian could be relevant Bavarian Nordic already has experience with: • mosquito-borne diseases • government vaccine contracts • rapid development of emergency vaccines. For example, they have developed a vaccine against Chikungunya, which is also a mosquito-borne virus. If the EU or USA decides to build up a stock of a West Nile vaccine, Bavarian is a type of company that can typically get such contracts·6 t sittenBut now, blackbirds are, all things considered, not homo sapiens. And that something transmits from a mosquito to humans doesn't mean much in relation to one mosquito-related vaccine and another mosquito-related vaccine.·6 t sittenIt is the University of Copenhagen that is responsible for the collection, which is part of the EU-funded project OH4Surveillance. Here, 11 European countries collaborate to monitor diseases that can infect both animals and humans. They are called zoonotic diseases. /ritzau/
- ·1 päivä sittenA strong signal that Paul Chaplin buys shares privately in Bavarian Nordic for 1,9 mil at a price of 176,65. C25-CEO buys for almost 1,9 mio. kr. Paul Chaplin is CEO of Bavarian Nordic. Paul Chaplin is CEO of Bavarian Nordic. Asger Ladefoged lans Laura Nørkjær Seligmann Journalist The CEO of Bavarian Nordic Paul Chaplin has gone on a share purchase. This can be read in a stock exchange announcement from the Danish vaccine company Thursday evening. He has bought 10.642 shares at an average price of 177,65 kr. He has thus bought shares for almost 1,9 mio. kr. Back in early March, it was announced that Paul Chaplin will step down as CEO of Bavarian Nordic after 27 years in the company. He will remain in the position until the end of 2026 or until the new CEO is found. Paul Chaplin's share purchase took place Thursday, March 12 - the same day Bavarian Nordic released its annual report. However, there was not much excitement associated with the report, as Bavarian Nordic merely maintained the preliminary figures that the company had issued in early February.·1 päivä sittenThese are RSV shares and thus part of Chaplin's compensation package.1 päivä sitten · Muokattu1 päivä sitten · MuokattuCiterer hermed PR " Køb (overdragelse af Restricted Stock Units)" Der står ikke RSV, men Restricted Stock Units (RSU). Same same..... Drømmer vist stadig om RSV (vaccinen som fejlede big time :-)
- ·12.3.Insanely low P/E with new report. Considering buying into this :)·1 päivä sittenYou should be aware that in 2025 they booked a one-off income of 810 mio kr for the sale of a priority voucher. At the same time, revenue is expected to fall somewhat in 2026 as the peak of mpx vaccines is now nearing completion. The underlying travel vaccine business is growing nicely, however, and especially the new Chikungunya-vaccine is promising, so there can certainly be reasons to buy into the company, but p/E for 2025 should be taken with a grain of salt. And yes, the portfolio you share here on the platform has 100% cash. It can of course be a mistake or you may have several portfolios, but it immediately appears to us others that you have cash.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 244 | - | - | ||
| 158 | - | - | ||
| 325 | - | - | ||
| 483 | - | - | ||
| 545 | - | - |
Välittäjätilasto
Dataa ei löytynyt